FDA approves most expensive drug ever, a $3.5 million-per-dose gene therapy for hemophilia B
The single-dose medicine "represents important progress" as the first-ever gene therapy for the rare disorder, the FDA said.
Continue ReadingThe single-dose medicine "represents important progress" as the first-ever gene therapy for the rare disorder, the FDA said.
Continue Reading
Join the Discussion